NCRI 2019

03–05 November 2019 | Glasgow, UK

The 2019 National Cancer Research Institute (NCRI) Annual Cancer Conference, took place on 3-5 November in Glasgow, UK. Watch our expert interviews from the largest cancer research conference in the UK.

NCRI 2019

03–05 November 2019 | Glasgow, UK

The 2019 National Cancer Research Institute (NCRI) Annual Cancer Conference, took place on 3-5 November in Glasgow, UK. Watch our expert interviews from the largest cancer research conference in the UK.

Multiplexing immunohistochemistry: the next revolution in molecular pathology? 2:55
Multiplexing immunohistochemistry: the next revolution in molecular pathology?
Matt Humphries
Limitations of precision medicine to be addressed 3:17
Limitations of precision medicine to be addressed
Ian Tannock
Digital pathology and AI for tissue segmentation 3:23
Digital pathology and AI for tissue segmentation
Viktor Koelzer
Interventional pharmoeconomics to reduce the cost of therapy 3:59
Interventional pharmoeconomics to reduce the cost of therapy
Mark Ratain
Strategies to reduce drug costs 4:06
Strategies to reduce drug costs
Mark Ratain
Immunotherapy – from bench to bedside 2:48
Immunotherapy – from bench to bedside
Kevin Litchfield
Areas to address when planning clinical trials 3:00
Areas to address when planning clinical trials
Martin Christlieb
Breaking the obesity-cancer link 4:44
Breaking the obesity-cancer link
Stephen Hursting
The thinking behind precision medicine for cancer therapy 2:38
The thinking behind precision medicine for cancer therapy
Ian Tannock
Clinical studies of obesity in oncogenesis and treatment response 3:38
Clinical studies of obesity in oncogenesis and treatment response
Stephen Hursting
Cell cycle-dependent regulation of mTORC1 signaling 3:14
Cell cycle-dependent regulation of mTORC1 signaling
Simon Cook
Clear communication in cancer research 1:35
Clear communication in cancer research
Martin Christlieb
Digital image analysis of the tumor microenvironment 3:17
Digital image analysis of the tumor microenvironment
Stephanie Craig
HER-2 conversion: a phenomenon in trastuzumab resistance 2:13
HER-2 conversion: a phenomenon in trastuzumab resistance
Russell Petty
Colorectal cancer subtyping using a histology based approach 4:31
Colorectal cancer subtyping using a histology based approach
Joanne Edwards
Robotic technology: hype or game changers? 2:36
Robotic technology: hype or game changers?
Peter McCulloch

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter

Subscribe now
The content of VJOncology is intended for healthcare professionals